Obesity, a global health issue, has seen a significant increase in prevalence over the past few decades. As healthcare professionals, it is crucial to devise and implement effective strategies to manage this complex, multifactorial condition.
Obesity is not merely an issue of aesthetics; it is a chronic disease characterized by excessive fat accumulation that may impair health. It is associated with a plethora of comorbidities, including diabetes, hypertension, and cardiovascular disease, which necessitates its efficient management.
Effective obesity management begins with a comprehensive patient assessment. This includes evaluating the patient's medical history, physical examination, and laboratory tests. Additionally, psychosocial factors that may contribute to obesity, such as depression or binge-eating disorders, should be considered.
The cornerstone of obesity management is lifestyle modification. This includes dietary changes, increased physical activity, and behavioral modifications. Healthcare professionals should guide patients in setting realistic goals and provide continuous support and motivation.
When lifestyle modifications alone are insufficient, pharmacological therapy may be necessary. Anti-obesity medications can be used as adjuncts to diet and exercise in patients with a BMI of 30 or above, or 27 and above with comorbidities.
Bariatric surgery may be considered in patients with severe obesity (BMI>40) or in those with a BMI of 35 or more with significant comorbidities. It has proven to be effective in achieving significant and sustained weight loss.
Managing obesity requires a multifaceted approach that includes lifestyle changes, pharmacological interventions, and possibly surgical procedures. As healthcare professionals, understanding and implementing these strategies can significantly improve patient outcomes and reduce the burden of obesity-related comorbidities.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation